In a significant development, LungLife AI Inc (AIM: LLAI), a pioneer in diagnostic solutions for early lung cancer detection, experienced a substantial surge in its shares, with prices jumping by a staggering 43%. The remarkable spike came on the heels of the successful validation of LungLife AI’s LungLB test, a vital tool in the detection
